Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different treatment durations of recombinant human brain natriuretic peptide in elderly heart failure patients
ChiCTR2600116729Phase 4Not yet recruiting
- Sponsor
- Shanxi Bethune Hospital
- Start
- Jan 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of nesiritide in heart failure (HF) (2 arms), sponsored by Shanxi Bethune Hospital. Primary endpoint: NT-proBNP at month 1. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
nesiritide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ChiCTR2600116729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116729.